Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4032) 4032
Magazine Article (17) 17
Newsletter (10) 10
Book Chapter (5) 5
Reference (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3467) 3467
science & technology (2474) 2474
life sciences & biomedicine (2423) 2423
female (1737) 1737
male (1650) 1650
adrenergic beta-agonists - therapeutic use (1511) 1511
asthma - drug therapy (1452) 1452
adrenergic beta-agonists - adverse effects (1419) 1419
adult (1147) 1147
adrenergic beta-agonists - administration & dosage (1068) 1068
biological and medical sciences (1049) 1049
medical sciences (1019) 1019
middle aged (1008) 1008
administration, inhalation (972) 972
abridged index medicus (884) 884
respiratory system (856) 856
asthma (802) 802
aged (716) 716
animals (668) 668
adrenergic beta-agonists - pharmacology (637) 637
general & internal medicine (599) 599
treatment outcome (588) 588
drug therapy, combination (582) 582
pharmacology. drug treatments (549) 549
bronchodilator agents - therapeutic use (547) 547
bronchodilator agents - administration & dosage (526) 526
adolescent (517) 517
child (509) 509
drug therapy (507) 507
double-blind method (504) 504
bronchodilator agents - adverse effects (500) 500
pulmonary disease, chronic obstructive - drug therapy (490) 490
pharmacology & pharmacy (403) 403
albuterol - administration & dosage (396) 396
albuterol - adverse effects (382) 382
asthma - physiopathology (380) 380
albuterol - therapeutic use (379) 379
albuterol - analogs & derivatives (349) 349
adrenal cortex hormones - therapeutic use (347) 347
dose-response relationship, drug (347) 347
medicine, general & internal (343) 343
time factors (338) 338
cardiovascular system & cardiology (335) 335
salmeterol xinafoate (330) 330
cardiac & cardiovascular systems (321) 321
adrenal cortex hormones - administration & dosage (316) 316
risk factors (313) 313
pregnancy (310) 310
anti-asthmatic agents - therapeutic use (287) 287
allergy (277) 277
randomized controlled trials as topic (266) 266
pneumology (260) 260
lung diseases, obstructive (259) 259
formoterol fumarate (256) 256
chronic obstructive pulmonary disease (255) 255
care and treatment (253) 253
critical care medicine (250) 250
heart rate - drug effects (249) 249
adrenergic beta-2 receptor agonists - administration & dosage (229) 229
asthma - mortality (227) 227
child, preschool (226) 226
dosage and administration (223) 223
immunology (223) 223
research (220) 220
chronic obstructive pulmonary disease, asthma (219) 219
nebulizers and vaporizers (218) 218
forced expiratory volume (214) 214
drug administration schedule (210) 210
health aspects (208) 208
pulmonary disease, chronic obstructive - physiopathology (205) 205
drug combinations (204) 204
anti-asthmatic agents - administration & dosage (201) 201
anti-asthmatic agents - adverse effects (200) 200
adrenergic beta agonists (191) 191
forced expiratory volume - drug effects (191) 191
isoproterenol - pharmacology (191) 191
severity of illness index (188) 188
adrenergic beta-2 receptor agonists - adverse effects (184) 184
corticosteroids (182) 182
ethanolamines - adverse effects (182) 182
cross-over studies (181) 181
adrenal cortex hormones - adverse effects (180) 180
rats (180) 180
copd (177) 177
ethanolamines - administration & dosage (176) 176
adrenergic beta-2 receptor agonists - therapeutic use (170) 170
ethanolamines - therapeutic use (170) 170
aged, 80 and over (163) 163
analysis (162) 162
clinical trials as topic (160) 160
salmeterol (159) 159
blood pressure - drug effects (158) 158
glucocorticoids - therapeutic use (156) 156
medicine & public health (155) 155
respiratory function tests (154) 154
pediatrics (152) 152
adrenergic beta-antagonists - therapeutic use (150) 150
albuterol (148) 148
mortality (148) 148
administration, oral (146) 146
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3727) 3727
German (115) 115
French (84) 84
Japanese (38) 38
Spanish (38) 38
Dutch (19) 19
Italian (15) 15
Swedish (14) 14
Danish (13) 13
Russian (13) 13
Polish (12) 12
Chinese (7) 7
Norwegian (7) 7
Portuguese (7) 7
Hungarian (4) 4
Romanian (4) 4
Bulgarian (2) 2
Lithuanian (2) 2
Czech (1) 1
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Safety of Long-Acting Beta-Agonists — An Urgent Need to Clear the Air
by Martinez, Fernando D
The New England journal of medicine, ISSN 0028-4793, 12/2005, Volume 353, Issue 25, pp. 2637 - 2639
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Asthma - mortality | Ethanolamines - adverse effects | Formoterol Fumarate | Salmeterol Xinafoate | United States | Humans | Albuterol - analogs & derivatives | United Kingdom | Clinical Trials as Topic | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Albuterol - therapeutic use | Ethanolamines - therapeutic use | Adrenergic beta-Agonists - therapeutic use | Drug Therapy, Combination | Adrenergic beta-Agonists - adverse effects | Albuterol - adverse effects | Complications and side effects | Public health advisory groups | Laws, regulations and rules | Risk factors | Salmeterol | Asthma | Confidence intervals | Hypotheses | Drug therapy | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Balancing the Benefits and Risks of Inhaled Long-Acting Beta-Agonists — The Influence of Values
by Kramer, Judith M
The New England journal of medicine, ISSN 0028-4793, 04/2009, Volume 360, Issue 16, pp. 1592 - 1595
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Risk Assessment | United States | Humans | Administration, Inhalation | Drug Approval | Asthma - drug therapy | Advisory Committees | Drug Labeling | Adrenergic beta-Agonists - therapeutic use | Bronchodilator Agents - adverse effects | Delayed-Action Preparations | Adrenergic beta-Agonists - adverse effects | United States Food and Drug Administration | Complications and side effects | Usage | Salmeterol | Adrenergic beta agonists | Formoterol | Drug therapy, Combination | Drug therapy | Asthma | Pediatrics | Teenagers | Meetings | Committees | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cardiovascular effects of β-agonists in patients with asthma and COPD: A meta-analysis
by Salpeter, Shelley R and Ormiston, Thomas M and Salpeter, Edwin E
Chest, ISSN 0012-3692, 2004, Volume 125, Issue 6, pp. 2309 - 2321
Adrenergic β-agonists | Adverse effects | Cardiovascular | Asthma | COPD | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Asthma - diagnosis | Pulmonary Disease, Chronic Obstructive - mortality | Severity of Illness Index | Asthma - mortality | Pulmonary Disease, Chronic Obstructive - diagnosis | Drug Administration Schedule | Risk Assessment | Humans | Male | Survival Rate | Cardiovascular System - drug effects | Asthma - drug therapy | Randomized Controlled Trials as Topic | Dose-Response Relationship, Drug | Female | Adrenergic beta-Agonists - therapeutic use | Respiratory Function Tests | Adrenergic beta-Agonists - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Adverse effects of β-agonists
by Sears, Malcolm R
Journal of allergy and clinical immunology, ISSN 0091-6749, 12/2002, Volume 110, Issue 6, pp. S322 - S328
Airway responsiveness | asthma mortality | cardiotoxicity | β-agonist | inflammation | Inflammation | Cardiotoxicity | Asthma mortality | Genotype | Clinical Trials as Topic | Pharmaceutical Preparations | Bronchodilator Agents - adverse effects | Humans | Adrenergic beta-Agonists - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Risks of Long-Acting Beta-Agonists in Achieving Asthma Control
by Drazen, Jeffrey M and O'Byrne, Paul M
The New England journal of medicine, ISSN 0028-4793, 04/2009, Volume 360, Issue 16, pp. 1671 - 1672
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Risk Assessment | Humans | Adrenergic beta-Agonists - therapeutic use | Bronchodilator Agents - adverse effects | Asthma - drug therapy | Adrenergic beta-Agonists - adverse effects | Prevention | Adrenergic beta agonists | Complications and side effects | Drug therapy | Salmeterol | Asthma | Respiratory therapy | Clinical trials | Pediatrics | Meetings | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Effects of short- and long-acting beta-agonists on asthma exacerbations: a prospective cohort
by Van Ganse, Eric and Texier, Nathalie and Dima, Alexandra L and Belhassen, Manon and Laforest, Laurent and Herbage, Sandrine and Schuck, Stéphane and Hernandez, Gimena and Garin, Olatz and Ferrer, Montse and de Bruin, Marijn and ASTRO-LAB group and ASTRO-LAB Grp
Annals of allergy, asthma, & immunology, ISSN 1081-1206, 03/2020, Volume 124, Issue 3, pp. 254 - 260
Pulmonary and Respiratory Medicine | Immunology and Allergy | Immunology | Allergy | Life Sciences & Biomedicine | Science & Technology | Anti-Asthmatic Agents - adverse effects | Asthma - diagnosis | Severity of Illness Index | Follow-Up Studies | Anti-Asthmatic Agents - therapeutic use | Humans | Male | Treatment Outcome | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Young Adult | Adrenal Cortex Hormones - adverse effects | Adolescent | Adrenergic beta-Agonists - administration & dosage | Biomarkers | Adult | Female | Adrenergic beta-Agonists - therapeutic use | Anti-Asthmatic Agents - administration & dosage | Odds Ratio | Child | Adrenergic beta-Agonists - adverse effects | Adrenal Cortex Hormones - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Meta-analysis: Effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths
by Salpeter, Shelley R and Buckley, Nicholas S and Ormiston, Thomas M and Salpeter, Edwin E
Annals of internal medicine, ISSN 0003-4819, 06/2006, Volume 144, Issue 12, pp. 904 - 912
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Anti-Asthmatic Agents - adverse effects | Asthma - mortality | Recurrence | Ethanolamines - adverse effects | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Humans | Hospitalization - statistics & numerical data | Male | Ethanolamines - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Child | Adrenergic beta-Agonists - adverse effects | Salmeterol Xinafoate | Drug Administration Schedule | Risk Factors | Albuterol - analogs & derivatives | Treatment Outcome | Asthma - drug therapy | Randomized Controlled Trials as Topic | Anti-Asthmatic Agents - administration & dosage | Albuterol - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children
by Ni Chroinin, Muireann and Lasserson, Toby J and Greenstone, Ilana and Ducharme, Francine M
Cochrane database of systematic reviews, ISSN 1469-493X, 2009, Issue 3, pp. CD007949 - CD007949
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anti-Asthmatic Agents - adverse effects | Beclomethasone - administration & dosage | Formoterol Fumarate | Salmeterol Xinafoate | Humans | Albuterol - analogs & derivatives | Male | Asthma - drug therapy | Ethanolamines - administration & dosage | Adrenal Cortex Hormones - adverse effects | Adolescent | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Beclomethasone - adverse effects | Female | Anti-Asthmatic Agents - administration & dosage | Drug Therapy, Combination | Child | Adrenergic beta-Agonists - adverse effects | Adrenal Cortex Hormones - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Long-acting Beta-Agonists with and without Inhaled Corticosteroids and Catastrophic Asthma Events
by Salpeter, Shelley R., MD, FACP and Wall, Andrew J., MD and Buckley, Nicholas S
The American journal of medicine, ISSN 0002-9343, 2010, Volume 123, Issue 4, pp. 322 - 328.e2
Internal Medicine | Inhaled corticosteroids | Intubation | Long-acting beta-agonists | Mortality | Asthma | Meta-analysis | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Anti-Asthmatic Agents - adverse effects | Asthma - mortality | Humans | Administration, Inhalation | Male | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Adrenal Cortex Hormones - adverse effects | Asthma - complications | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Adrenergic beta-Agonists - therapeutic use | Intubation, Intratracheal | Odds Ratio | Child | Adrenergic beta-Agonists - adverse effects | Adrenal Cortex Hormones - administration & dosage | Steroids | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma
by Chowdhury, Badrul A and Dal Pan, Gerald
The New England journal of medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 13, pp. 1169 - 1171
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Asthma - mortality | United States | Humans | Administration, Inhalation | Drug Approval | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Contraindications | Drug Labeling - legislation & jurisprudence | Adrenergic beta-Agonists - therapeutic use | Drug Therapy, Combination | Delayed-Action Preparations | Adrenergic beta-Agonists - adverse effects | United States Food and Drug Administration | Adrenergic beta agonists | Complications and side effects | Reports | Usage | Drug therapy | Asthma | Studies | Confidence intervals | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Safety of long-acting β-agonists: Are new data really required?
by Sears, Malcolm R
Chest, ISSN 0012-3692, 08/2009, Volume 136, Issue 2, pp. 604 - 607
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Asthma - mortality | United States | Humans | Male | Delayed-Action Preparations - administration & dosage | Dose-Response Relationship, Drug | Drug-Related Side Effects and Adverse Reactions | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Female | Drug Therapy, Combination | Adrenergic beta-Agonists - adverse effects | United States Food and Drug Administration | Needs Assessment | Asthma - diagnosis | Severity of Illness Index | Salmeterol Xinafoate | Drug Administration Schedule | Risk Assessment | Administration, Inhalation | Albuterol - analogs & derivatives | Survival Rate | Asthma - drug therapy | Randomized Controlled Trials as Topic | Adrenal Cortex Hormones - adverse effects | Delayed-Action Preparations - adverse effects | Respiratory Function Tests | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Reply: Adverse effects of long-acting beta-agonists on airway hyperresponsiveness
by Forkuo, Gloria S and Thanawala, Vaidehi J and Al-Sawalha, Nour and Bond, Richard A and Walker, Julia K. L
American journal of respiratory cell and molecular biology, ISSN 1044-1549, 09/2013, Volume 49, Issue 3, pp. 502 - 502
Respiratory System | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Ethanolamines - pharmacology | Animals | Asthma - chemically induced | Adrenergic beta-2 Receptor Agonists - pharmacology | Disease Models, Animal | Index Medicus | Correspondence
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text The safety of long-acting β-agonists among patients with asthma using inhaled corticosteroids: Systematic review and metaanalysis
by Jaeschke, Roman and O'Byrne, Paul M and Mejza, Filip and Nair, Parameswaran and Leśniak, Wiktoria and Brozek, Jan and Thabane, Lehana and Cheng, Ji and Schünemann, Holger J and Sears, Malcolm R and Guyatt, Gordon
American journal of respiratory and critical care medicine, ISSN 1073-449X, 11/2008, Volume 178, Issue 10, pp. 1009 - 1016
Long-acting β-agonists | Systematic review | Adverse events | Randomized trials | Toxicity | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Drug Interactions | Humans | Administration, Inhalation | Adrenergic beta-Antagonists - adverse effects | Drug Therapy, Combination | Asthma - drug therapy | Adrenal Cortex Hormones - administration & dosage | Randomized Controlled Trials as Topic | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights